tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Elanco raises FY25 adjusted EPS view to 85c-91c from 80c-86c, consensus 84c

Raises FY25 revenue view to $4.57B-$4.62B from $4.51B-$4.58B, consensus $4.54B. Raises FY25 adjusted EBITDA view to $850M-$890M from $830M-$870M. “I am thrilled to be part of the Elanco (ELAN) team as the company is entering its next era of growth,” said Bob VanHimbergen, executive VP and CFO of Elanco Animal Health. “We are raising our 2025 full-year guidance for our strong second quarter execution and more favorable foreign exchange rates, more than offsetting incremental investments to fuel our innovation launches. I’m confident in our ability to execute on our plans, and my initial agenda is focused on driving value creation through a continuation of our productivity and cash generation efforts.”

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1